No-go decision: A newly identified adverse event in orthopaedic surgery - causes and medico-legal implications.

Background: No-go designates a decision not to perform surgery when it becomes apparent that safety and/or feasibility requirements are not met. No-go decisions can occur at any time between patient admission to a hospital department and immediately before the first incision. The primary objective of this study was to assess the causes of no-go decisions reported as healthcare-associated adverse events (HAAEs).

[Autoclaved tumoral autografts. Apropos of 12 cases, 6 of which highly malignant].

Twelve patients presenting with a bone tumor were operated on using autoclaved bone autografts for reconstruction following carcinologic resection. According to the Enneking grading system, 6 were high malignancy tumors (3 osteosarcomas and 3 grade 2 chondrosarcomas), 4 were low grade tumors (1 paraosteal sarcoma, 1 chondrosarcoma, 1 secondary chondrosarcoma, 1 liposarcoma). One was a metastasis from a kidney tumor.

[Surgical treatment of metastases of the acetabulum].

The lytic metastasis of the acetabulum are frequent, causing pathologic fractures, pain and disability. The authors analyze 42 acetabular metastases operated on between 1976 and 1986. Thirty-nine total hip replacements were made, 9 conventional arthroplasties for minor lesions, and 30 metallo-acrylic reconstructive surgery of the acetabulum combined in 8 cases to bone grafting of more extensive lesions.